Recommend Products

Special Offer

Bulk Products

New Arrivals

Hot Sales

Publication Products

Publication Products

Chemical Structure Cat. No. Product Name CAS No.
Cabazitaxel Chemical Structure
BCP27641 Cabazitaxel 183133-96-2
A novel semi-synthetic taxane with antitumor activity used for the treatment of castration-resistant prostate cancer. A microtubule inhibitor.
PA-824 Chemical Structure
BCP21111 PA-824 187235-37-6
PA-824 is an experimental anti-tuberculosis drug and one of two nitroimidazoles in phase II clinical trials to treat tuberculosis.
Infliximab Chemical Structure
BCP20310 Infliximab 170277-31-3
Infliximab is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α) and is used to treat autoimmune diseases.
SU-6668 Chemical Structure
BCP01984 SU-6668 252916-29-3
TSU-68 (SU6668)is a novel multiple receptor tyrosine kinase inhibitor with IC50 of 2.1 μM, 8 nM and 1.2 μM for VEGF-R1, PDGF-Rβ and FGF-R1, respectively.
Trastuzumab emtansine Chemical Structure
BCP30527 Trastuzumab emtansine 1018448-65-1
Trastuzumab emtansine is an antibody-drug conjugate (ADC), a combination between a monoclonal antibody and a small-molecule drug. Each molecule of trastuzumab emtansine consists of a single trastuzumab molecule with several molecules of DM1, a cytotoxic maytansinoid, attached.
Wnt-C59 Chemical Structure
BCP07008 Wnt-C59 1243243-89-1
Wnt-C59 (C59) is a PORCN inhibitor for Wnt3A-mediated activation of a multimerized TCF-binding site driving luciferase with IC50 of 74 pM.
BMS 777607 Chemical Structure
BCP13190 BMS 777607 1196681-44-3
BMS 777607 is a novel, selective and orally available ATP-competitive MET kinase inhibitor that primarily targets several MET family members, including RON, MET, Tyro-3 and AxI, with half maximal inhibitory concentration IC50 of 1.8 nmol/L, 3.9 nmol/L, 4.3 nmol/L and 1.1 nmol/L respectively.
Argatroban Chemical Structure
BCP06831 Argatroban 74863-84-6
Argatroban is a direct, selective thrombin inhibitor.
Plerixafor Chemical Structure
BCP02337 Plerixafor 110078-46-1
Plerixafor (AMD3100) is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively.
Rapamycin Chemical Structure
BCP01404 Rapamycin 53123-88-9
Rapamycin is antifungal and immunosuppressant and specific inhibitor of mTOR.
WYE-125132 Chemical Structure
BCP02227 WYE-125132 1144068-46-1
WYE-125132 is a highly potent, ATP-competitive and specific mTOR kinase inhibitor with an IC50 of 0.19 nM.
AZD8055 Chemical Structure
BCP02171 AZD8055 1009298-09-2
AZD-8055 is a potent, selective, and orally bioavailable ATP-competitive mTOR kinase inhibitor with an IC50 of 0.8 nM.
Conivaptan Chemical Structure
BCP07817 Conivaptan 210101-16-9
Conivaptan is a nonpeptide dual V1a/V2 AVP receptor antagonist.
Talazoparib Chemical Structure
BCP07266 Talazoparib 1207456-01-6
Talazoparib (BMN-673) is a highly potent PARP1/2 inhibitor with Kis of 1.2 nM and 0.87 nM, respectively.
Chloral hydrate Chemical Structure
BCP31225 Chloral hydrate 302-17-0
Chloral hydrate is a mild hypnotic that is used to treat simple insomnia. Despite many years of use, chloral hydrate has not been implicated in causing serum enzyme elevations or clinically apparent liver injury.
GRGDNP Chemical Structure
BCP15902 GRGDNP 114681-65-1
RGD peptide is a synthetic compound made up of the arginine-glycine-aspartate motif that has been extensively used to inhibit integrin-ligand interactions in studies related to cell adhesion, migration, growth, and differentiation.
Bedaquiline Chemical Structure
BCP02829 Bedaquiline 843663-66-1
Bedaquiline, also known as TMC207 and R207910, is a diarylquinoline anti-tuberculosis drug.
Clofazimine Chemical Structure
BCP07792 Clofazimine 2030-63-9
Clofazimine is a fat-soluble iminophenazine dye, has a marked anti-inflammatory effect, has been used in combination with other antimycobacterial drugs to treat AIDS and Crohn's disease.
GDC-0941 Chemical Structure
BCP01714 GDC-0941 957054-30-7
GDC-0941 is a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer.
PI-103 Chemical Structure
BCP01923 PI-103 371935-74-9
PI-103 is inhibitor of DNA-PK, PI 3-kinase (p110α) and mTOR.
123下一頁共 45 條記錄 1 / 3 頁 
<蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <文本链> <文本链> <文本链> <文本链> <文本链> <文本链>